Used in the synthesis of prostaglandin analogs, particularly in the development of ophthalmic drugs for treating glaucoma. It serves as a key chiral intermediate in producing biologically active molecules with high stereoselectivity. Its structure supports the formation of complex ring systems found in therapeutic agents targeting intraocular pressure reduction. Commonly employed in pharmaceutical research and development due to its compatibility with multi-step organic transformations.